Virtual screening of some active human macrophage migration inhibitory factor antagonists

Journal of Biomolecular Screening

Volumn 19, Issue 7, 2014, Pages 1116-1123

  Tsai, Tsung Lin ^a   Lin, Thy Hou ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

inhibitors; MIF tautomerase; virtual screening

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; MACROPHAGE MIGRATION INHIBITORY FACTOR ANTAGONIST; UNCLASSIFIED DRUG; ZINC 00141102; ZINC 00151739; ZINC 00543667; ZINC 00619771; ZINC 02693801; ZINC 02693861; ZINC 03214604; ZINC 04756057; ZINC 09156073; ZINC 12368346; ZINC 13581715; ZINC 15074093; ZINC 19872043; ZINC 20228902; ZINC 21835697; ZINC 24237833; ZINC 24740881; ISOMERASE; LIGAND; MACROPHAGE MIGRATION INHIBITION FACTOR; MIF PROTEIN, HUMAN; RECOMBINANT PROTEIN; THIAZOLE DERIVATIVE;

ARTICLE; BREAST EPITHELIUM; CELL LYSATE; CELL PROLIFERATION ASSAY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG SCREENING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL; VIRTUAL SCREENING; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; COMPUTER SIMULATION; CYTOLOGY; DRUG DEVELOPMENT; ENZYME ACTIVE SITE; HYDROGEN BOND; IC50; INFLAMMATION; MONOCYTE; PROCEDURES; PROTEIN DATABASE; STATISTICAL MODEL; X RAY;

CATALYTIC DOMAIN; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER SIMULATION; DATABASES, PROTEIN; DRUG DISCOVERY; HUMANS; HYDROGEN BONDING; INFLAMMATION; INHIBITORY CONCENTRATION 50; INTRAMOLECULAR OXIDOREDUCTASES; LIGANDS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MODELS, STATISTICAL; MONOCYTES; RECOMBINANT PROTEINS; THIAZOLES; X-RAYS;

EID: 84904706520     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057114523317     Document Type: Article

References (30)

1. Rendon B. E., Willer S. S., Zundel W., et al. Mechanisms of Macrophage Migration Inhibitory Factor (Mif)-Dependent Tumor Microenvironmental Adaptation. Exp. Mol. Pathol. 2009 ; 86: 180-185
2. Matsunaga J., Sinha D., Solano F., et al. Macrophage Migration Inhibitory Factor (Mif): Its Role in Catecholamine Metabolism. Cell Mol. Biol. 1999 ; 45: 1035-1040
3. Calandra T., Roger T.. Macrophage Migration Inhibitory Factor: A Regulator of Innate Immunity. Nat. Rev. Immunol. 2003 ; 3: 791-800
4. Flaster H., Bernhagen J., Calandra T., et al. The Macrophage Migration Inhibitory Factor-Glucocorticoid Dyad: Regulation of Inflammation and Immunity. Mol. Endocrinol. 2007 ; 21: 1267-1280
5. Nishihira J., Ishibashi T., Fukushima T., et al. Macrophage Migration Inhibitory Factor (Mif): Its Potential Role in Tumor Growth and Tumor-Associated Angiogenesis. Ann. N.Y. Acad. Sci. 2003 ; 995: 171-182
6. Hudson J. D., Shoaibi M. A., Maestro R., et al. A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity. J. Exp. Med. 1999 ; 190: 1375-1382
7. Winner M., Koong A. C., Rendon B. E., et al. Amplification of Tumor Hypoxic Responses by Macrophage Migration Inhibitory Factor-Dependent Hypoxia-Inducible Factor Stabilization. Cancer Res. 2007 ; 67: 186-193
8. Hussain F., Freissmuth M., Volkel D., et al. Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo. Mol. Cancer Ther. 2013 ; 12: 1223-1234
9. Bai F., Asojo O. A., Cirillo P., et al. A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (Mif). J. Biol. Chem. 2012 ; 287: 30653-30663
10. Garai J., Lorand T.. Macrophage Migration Inhibitory Factor (Mif) Tautomerase Inhibitors as Potential Novel Anti-Inflammatory Agents: Current Developments. Curr. Med. Chem. 2009 ; 16: 1091-1114
11. Shoichet B. K.. Virtual Screening of Chemical Libraries. Nature. 2004 ; 432: 862-865
12. Rester U.. From Virtuality to Reality - Virtual Screening in Lead Discovery and Lead Optimization: A Medicinal Chemistry Perspective. Curr. Opin. Drug Discov. Dev. 2008 ; 11: 559-568
13. Kitchen D. B., Decornez H., Furr J. R., et al. Docking and Scoring in Virtual Screening for Drug Discovery: Methods and Applications. Nat. Rev. Drug Discov. 2004 ; 3: 935-949
14. Ballester P. J., Richards W. G.. Ultrafast Shape Recognition to Search Compound Databases for Similar Molecular Shapes. J. Comput. Chem. 2007 ; 28: 1711-1723
15. Lipinski C. A., Lombardo F., Dominy B. W., et al. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Adv. Drug Deliv. Rev. 2001 ; 46: 3-26
16. Lin T. H., Lin G. L.. An Anchor-Dependent Molecular Docking Process for Docking Small Flexible Molecules into Rigid Protein Receptors. J. Chem. Inf. Model. 2008 ; 48: 1638-1655
17. El Turk F., Fauvet B., Ouertatani-Sakouhi H., et al. An Integrative In Silico Methodology for the Identification of Modulators of Macrophage Migration Inhibitory Factor (Mif) Tautomerase Activity. Bioorg. Med. Chem. 2010 ; 18: 5425-5440
18. Orita M., Yamamoto S., Katayama N., et al. Coumarin and Chromen-4-One Analogues as Tautomerase Inhibitors of Macrophage Migration Inhibitory Factor: Discovery and X-Ray Crystallography. J. Med. Chem. 2001 ; 44: 540-547
19. Cournia Z., Leng L., Gandavadi S., et al. Discovery of Human Macrophage Migration Inhibitory Factor (Mif)-Cd74 Antagonists via Virtual Screening. J. Med. Chem. 2009 ; 52: 416-424
20. Crichlow G. V., Cheng K. F., Dabideen D., et al. Alternative Chemical Modifications Reverse the Binding Orientation of a Pharmacophore Scaffold in the Active Site of Macrophage Migration Inhibitory Factor. J. Biol. Chem. 2007 ; 282: 23089-23095
21. Gasteiger J., Marsili M.. Iterative Partial Equalization of Orbital Electronegativity: A Rapid Access to Atomic Charges. Tetrahedron. 1980 ; 36: 3219-3228
22. Xing L., Glen R. C.. Novel Methods for the Prediction of Logp, Pk(a), and Logd. J. Chem. Inf. Comput. Sci. 2002 ; 42: 796-805
23. Wang J. M., Xie X. Q., Hou T. J., et al. Fast Approaches for Molecular Polarizability Calculations. J. Phys. Chem. A. 2007 ; 111: 4443-4448
24. Dagia N. M., Kamath D. V., Bhatt P., et al. A Fluorinated Analog of Iso-1 Blocks the Recognition and Biological Function of Mif and Is Orally Efficacious in a Murine Model of Colitis. Eur. J. Pharmacol. 2009 ; 607: 201-212
25. Al-Abed Y., VanPatten S.. Mif as a Disease Target: Iso-1 as a Proof-of-Concept Therapeutic. Future Med. Chem. 2011 ; 3: 45-63
26. Bajorath F.. Integration of Virtual and High-Throughput Screening. Nat. Rev. Drug Discov. 2002 ; 1: 882-894
27. Lubetsky J. B., Dios A., Han J., et al. The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-Inflammatory Agents. J. Biol. Chem. 2002 ; 277: 24976-24982
28. Winner M., Meier J., Zierow S., et al. A Novel, Macrophage Migration Inhibitory Factor Suicide Substrate Inhibits Motility and Growth of Lung Cancer Cells. Cancer Res. 2008 ; 68: 7253-7257
29. Cheng K. F., Al-Abed Y.. Critical Modifications of the Iso-1 Scaffold Improve Its Potent Inhibition of Macrophage Migration Inhibitory Factor (Mif) Tautomerase Activity. Bioorg. Med. Chem. Lett. 2006 ; 16: 3376-3379
30. Sugimoto H., Taniguchi M., Nakagawa A., et al. Crystal Structure of Human D-Dopachrome Tautomerase, a Homologue of Macrophage Migration Inhibitory Factor, at 1.54 a Resolution. Biochemistry. 1999 ; 38: 3268-3279